{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:28:22Z","timestamp":1773311302168,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T00:00:00Z","timestamp":1513900800000},"content-version":"vor","delay-in-days":235,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Dutch Ministry of Economic Affairs"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.vaccine.2017.04.024","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T13:31:14Z","timestamp":1493299874000},"page":"3123-3128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy"],"prefix":"10.1016","volume":"35","author":[{"given":"Paul J.","family":"Wichgers Schreur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucien","family":"van Keulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jet","family":"Kant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Kortekaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.04.024_b0005","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis","volume":"81","author":"Won","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.04.024_b0010","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1038\/emi.2014.71","article-title":"The Rift Valley fever accessory proteins NSm and P78\/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts","volume":"3","author":"Kreher","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2017.04.024_b0015","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs","volume":"75","author":"Bouloy","year":"2001","journal-title":"J Virol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.04.024_b0020","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1111\/j.1749-6632.2009.05054.x","article-title":"Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR","volume":"1171","author":"Ikegami","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2017.04.024_b0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.virol.2012.09.031","article-title":"Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR","volume":"435","author":"Kalveram","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.04.024_b0030","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/JVI.01165-09","article-title":"Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects","volume":"84","author":"Mansuroglu","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.04.024_b0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2017.04.024_b0040","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.024_b0045","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Brit J Exp Pathol"},{"key":"10.1016\/j.vaccine.2017.04.024_b0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.04.024_b0055","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/JVI.74.3.1538-1543.2000","article-title":"The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice","volume":"74","author":"Vialat","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.04.024_b0060","doi-asserted-by":"crossref","first-page":"e2874","DOI":"10.1371\/journal.pntd.0002874","article-title":"Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model","volume":"8","author":"Dodd","year":"2014","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.vaccine.2017.04.024_b0065","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2011.05.055","article-title":"Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves","volume":"29","author":"von Teichman","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.024_b0070","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1016\/j.vaccine.2014.07.037","article-title":"Comparative efficacy of two next-generation Rift Valley fever vaccines","volume":"32","author":"Kortekaas","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.024_b0075","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.024_b0080","doi-asserted-by":"crossref","first-page":"e0004550","DOI":"10.1371\/journal.pntd.0004550","article-title":"Rift Valley fever vaccine virus clone 13 is able to cross the ovine placental barrier associated with foetal infections, malformations, and stillbirths","volume":"10","author":"Makoschey","year":"2016","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.vaccine.2017.04.024_b0085","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1128\/JVI.00961-14","article-title":"Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging","volume":"88","author":"Wichgers Schreur","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.04.024_b0090","doi-asserted-by":"crossref","first-page":"e1005800","DOI":"10.1371\/journal.ppat.1005800","article-title":"Single-molecule FISH reveals non-selective packaging of Rift Valley fever virus genome segments","volume":"12","author":"Wichgers Schreur","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.04.024_b0095","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.vaccine.2015.01.077","article-title":"Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination","volume":"33","author":"Wichgers Schreur","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.024_b0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/JVI.58.2.263-270.1986","article-title":"Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus","volume":"58","author":"Keegan","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.04.024_b0105","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1099\/vir.0.067660-0","article-title":"Paramyxovirus-based production of Rift Valley fever virus replicon particles","volume":"95","author":"Wichgers Schreur","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.04.024_b0110","first-page":"227","article-title":"The method of \u201cright and wrong cases\u201d (\u201cconstant stimuli\u201d) without Gauss's formulae","volume":"2","author":"Spearman","year":"1908","journal-title":"Br J Psychol"},{"key":"10.1016\/j.vaccine.2017.04.024_b0115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Arch Exp Path Pharmak"},{"key":"10.1016\/j.vaccine.2017.04.024_b0120","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill","year":"1987","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2017.04.024_b0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"Morrill","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.024_b0130","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep","volume":"69","author":"Hunter","year":"2002","journal-title":"Onderstepoort J Veter Res"},{"key":"10.1016\/j.vaccine.2017.04.024_b0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.vaccine.2012.10.118","article-title":"Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.024_b0140","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.vaccine.2013.08.003","article-title":"Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.024_b0145","unstructured":"Maartens LH. New developments in Rift Valley fever vaccination. Rift Valley fever: New options for Trade, Prevention and Control. Djibouti; 2015."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730498X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730498X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:48:33Z","timestamp":1750207713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1730498X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":29,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0264410X1730498X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}